跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,145 条关于
“EB-Haus Austria”
全部
2,145
临床试验
981
药物
136
机构
641
资讯
387
去年
RHEACELL and AOP Health Partner to Advance Stem Cell Therapy for Epidermolysis Bullosa and Chronic Venous Wounds
12个月前
DEBRA Research and Nonsense Therapeutics Form ReadOn Therapeutics to Advance Epidermolysis Bullosa Treatments
去年
Relief Therapeutics' RLF-TD011 Shows Promise in Epidermolysis Bullosa Trial
去年
Enveric Biosciences' EB-003 Shows Statistically Significant Antidepressant Effects in Preclinical Depression Model
去年
FDA Grants Rare Pediatric Disease Designation to Relief Therapeutics' EB Treatment RLF-TD011
去年
BioMendics Launches TAMES-02 Trial for First-in-Class EB Simplex Therapy TolaSure
去年
Enveric Biosciences Advances EB-003 Depression Treatment Directly to IND Submission Following FDA Guidance
2年前
LEQEMBI Launches in Austria and Germany as First Anti-Amyloid Alzheimer's Therapy in EU
去年
Eluminex Biosciences Reports Positive Phase 1b Results for Novel Pentavalent Antibody EB-105 in Diabetic Macular Edema
去年
Enveric Biosciences Advances EB-003 for Mental Health Disorders, Eyes 2025 IND Filing
第 1 页,共 39 页
上一页
下一页